[Effect of microsomal monooxygenase inductor zixoryn on clinico-immunologic indicators in allergologic patients].
Zixorine, an inducer of microsomal monoxygenases, can effectively be used for the treatment of patients with allergic dermatoses. It has been established that zixorine makes the NBT-test and the IgE content in the blood serum of these patients return to normal.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D051379:Mice; D008875:Middle Aged; D010587:Phagocytosis / Q000187:drug effects*; D014581:Urticaria / Q000188:drug therapy* / Q000378:metabolism
D001559:Benzhydryl Compounds; D003577:Cytochrome P-450 Enzyme System; C016914:flumecinol
Vliianie induktora mikrosomal'nykh monooksigenaz ziksorina na kliniko-immunologicheskie pokazateli u allergologicheskikh bol'nykh.